Zobrazeno 1 - 10
of 38
pro vyhledávání: '"K. S. Khuenl-Brady"'
Publikováno v:
Egyptian Journal for Aquaculture. 8:1-12
The time-course of the neuromuscular effects of vecuronium (n = 25) and atracurium (n = 25) has been compared at three different levels of maintenance dose in anaesthetized patients. Following intubation with vecuronium 0.1 mg kg-1 or atracurium 0.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c4ae2e8421122b176875e0d69e776d4
https://doi.org/10.21608/eja.2018.44524
https://doi.org/10.21608/eja.2018.44524
Autor:
K. S. Khuenl-Brady, Matthias Eikermann, Martine E. Prins, Andreas W. Sielenkämper, F Pühringer, Christopher Rex, Per Bo Larsen, Casper Claudius
Publikováno v:
Anesthesiology. 109:188-197
Background Sugammadex (Org 25969), a novel, selective relaxant binding agent, was specifically designed to rapidly reverse rocuronium-induced neuromuscular blockade. The efficacy and safety of sugammadex for the reversal of profound, high-dose rocuro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad63dcdbf67b0adb64286e9b2c9ccbb
https://doi.org/10.1097/aln.0b013e31817f5bc7
https://doi.org/10.1097/aln.0b013e31817f5bc7
Autor:
W. J. Herring, T. Woo, C. A. Assaid, R. J. Lupinacci, H. J. Lemmens, M. Blobner, K. S. Khuenl-Brady
Publikováno v:
Survey of Anesthesiology. 61:124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db4f67294b099a97c64259b12349187c
https://doi.org/10.1097/sa.0000000000000332
https://doi.org/10.1097/sa.0000000000000332
Publikováno v:
British Journal of Anaesthesia, 78(3), 267-273. ELSEVIER SCI LTD
We have studied dose requirements, recovery times and pharmacokinetics of rocuronium in 32 intensive care patients. After an initial dose of 50 mg, rocuronium was administered as maintenance doses of 25 mg whenever two responses to train-of-four (TOF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fd13247140c835f83a6ac72b538ce50
https://doi.org/10.1093/bja/78.3.267
https://doi.org/10.1093/bja/78.3.267
Autor:
H. J. Sparr, K. S. Khuenl-Brady
Publikováno v:
Clinical Pharmacokinetics. 31:174-183
A new aminosteroidal neuromuscular blocking agent, rocuronium bromide, has recently been introduced into clinical practice. Its main advantage over other currently used drugs of this kind is its fast onset of action, which could render rocuronium the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90548d4170dd8e8352b6b61101711abe
https://doi.org/10.2165/00003088-199631030-00002
https://doi.org/10.2165/00003088-199631030-00002
Publikováno v:
European Journal of Anaesthesiology. 13:478-482
Pipecuronium bromide, a long acting non-depolarizing neuromuscular blocking agent was administered to four groups of 10 patients using the priming technique. The effects of the combination of two different priming doses (0.01 or 0.015 mg kg-1) given
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dfeaa1f1fd882663af63934564046c1
https://doi.org/10.1097/00003643-199609000-00010
https://doi.org/10.1097/00003643-199609000-00010
Publikováno v:
Anesthesiology Clinics of North America. 11:345-360
SUMMARY Neuromuscular blocking agents, together with sedatives and analgesic drugs, provide the pharmacologic basis for controlled ventilation that can be a life-saving procedure in critically ill patients. During the last few years, an increasing nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be39ec744ea4d208a84d344925493f52
https://doi.org/10.1016/s0889-8537(21)00785-9
https://doi.org/10.1016/s0889-8537(21)00785-9
Publikováno v:
European Journal of Pharmacology. 222:153-156
The neuromuscular-blocking agent vecuronium bromide undergoes hydrolysis to three pharmacologically active metabolites (3-desacetyl, 17-desacetyl and 3,17-desacetyl vecuronium) which might modify the neuromuscular-blocking action of their parent comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0b747a8b897c7231e212ac8f23c0e5
https://doi.org/10.1016/0014-2999(92)90828-r
https://doi.org/10.1016/0014-2999(92)90828-r
Publikováno v:
Acta Anaesthesiologica Scandinavica, 36(3), 260-263. Wiley
The interaction of ORG 9426, a new non-depolarizing neuromuscular blocking agent, with intravenous anaesthetic drugs (fentanyl, thiopental, midazolam, droperidol and etomidate) has been investigated in cats. During an infusion of one of the above ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55261ce27724e8ffa81cb0cf6c55f95e
https://hdl.handle.net/11370/23e7a856-9489-4430-8019-76f02ca5c464
https://hdl.handle.net/11370/23e7a856-9489-4430-8019-76f02ca5c464
Autor:
José A. Alvarez-Gomez, Henk Rietbergen, K. S. Khuenl-Brady, José I. Lora-Tamayo, Magnus Wattwil, Bernard F. Vanacker
Publikováno v:
Anesthesia and analgesia. 110(1)
BACKGROUND: Sugammadex, a specifically designed -cyclodextrin, is a selective relaxant binding drug that rapidly reverses rocuronium-induced and, to a lesser extent, vecuronium-induced neuromuscular blockade. In this study, we compared the efficacy o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f927dec0df768b19a694525698298d
https://pubmed.ncbi.nlm.nih.gov/19713265
https://pubmed.ncbi.nlm.nih.gov/19713265